CoChat
Sign Up
Cited by 44

Military service and related risk factors for amyotrophic lateral sclerosis

McKay, Kyla A., Smith, Kelsi A., Smertinaite, Lidija, Fang, Fang, Ingre, Caroline, Taube, Fabian·2021·Acta Neurologica Scandinavica
DOI 10.1111/ane.13345PMC PMC7756624
Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/ane.13345

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 35

  1. [1]Hardiman O, van den Berg LH, Kiernan MC. Clinical diagnosis and management of amyotrophic lateral sclerosis. Nat Rev Neurol. 2011; 7: 639– 649. 21989247
  2. [2]Chio A, Logroscino G, Traynor BJ, et al. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology. 2013; 41(2): 118– 130. 23860588 PMC4049265
  3. [3]Al‐Chalabi A, Hardiman O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol. 2013; 9(11): 617– 628. 24126629
  4. [4]Mehta P, Kaye W, Raymond J, et al. Prevalence of Amyotrophic Lateral Sclerosis ‐ United States, 2014. MMWR ‐ Morb Mortal Wkly Rep. 2018; 67(7): 216– 218. 29470458 PMC5858037
  5. [5]Nelson LM, Topol B, Kaye W, et al. Estimation of the Prevalence of Amyotrophic Lateral Sclerosis in the United States Using National Administrative Healthcare Data from 2002 to 2004 and Capture‐Recapture Methodology. Neuroepidemiology. 2018; 51(3–4): 149– 157. 30092573 PMC6250049
  6. [6]Beard JD, Kamel F. Military service, deployments, and exposures in relation to amyotrophic lateral sclerosis etiology and survival. Epidemiol Rev. 2015; 37: 55– 70. 25365170 PMC4325667
  7. [7]Tai H, Cui L, Shen D, Li D, Cui B, Fang J. Military service and the risk of amyotrophic lateral sclerosis: A meta‐analysis. J Clin Neurosci. 2017; 45: 337– 342. 28864407
  8. [8]Marin B, Couratier P, Preux PM, Logroscino G. Can mortality data be used to estimate amyotrophic lateral sclerosis incidence? Neuroepidemiology. 2011; 36(1): 29– 38. 21088432
  9. [9]Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: A critical appraisal tool for systematic reviews that include randomised or non‐randomised studies of healthcare interventions, or both. BMJ (Research Methods Reporting). 2017; 358: 1– 9. PMC5833365 28935701
  10. [11]Andrew AS, Caller TA, Tandan R, et al. Environmental and occupational exposures and amyotrophic lateral sclerosis in New England. Neurodegener Dis. 2017; 17(2–3): 110– 116. 28122372 PMC5383428
  11. [12]Dickerson AS, Hansen J, Kioumourtzoglou MA, Specht AJ, Gredal O, Weisskopf MG. Study of occupation and amyotrophic lateral sclerosis in a Danish cohort. Occup Environ Med. 2018; 75(9): 630– 638. 29941657 PMC6445390
  12. [13]Peters TL, Kamel F, Lundholm C, et al. Occupational exposures and the risk of amyotrophic lateral sclerosis. Occup Environ Med. 2017; 74: 87– 92. 27418175 PMC5451107
  13. [14]Smith TC, Gray GC, Knoke JD. Is systemic lupus erythematosus, amyotrophic lateral sclerosis, or fibromyalgia associated with Persian Gulf War service? An examination of Department of Defense hospitalization data. Am J Epidemiol. 2000; 151(11): 1053– 1059. 10873128
  14. [15]Kang HK, Bullman TA. Mortality among US veterans of the Persian Gulf War: 7‐year follow‐up. Am J Epidemiol. 2001; 154(5): 399– 405. 11532780
  15. [16]Barth SK, Kang HK, Bullman TA, Wallin MT. Neurological mortality among U.S. veterans of the Persian Gulf War: 13‐year follow‐up. Am J Ind Med. 2009; 52(9): 663– 670. 19585544
  16. [17]Haley RW. Excess incidence of ALS in young Gulf War veterans. Neurology. 2003; 61(6): 750– 756. 14504316
  17. [18]Horner RD, Kamins KG, Feussner JR, et al. Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology. 2003; 61(6): 742– 749. 14504315
  18. [19]Coffman CJ, Horner RD, Grambow SC, Lindquist J, Project VACSP. Estimating the occurrence of amyotrophic lateral sclerosis among Gulf War (1990–1991) veterans using capture‐recapture methods. Neuroepidemiology. 2005; 24(3): 141– 150. 15650320
  19. [20]Beard JD, Engel LS, Richardson DB, et al. Military service, deployments, and exposures in relation to amyotrophic lateral sclerosis etiology. Environ Int. 2016; 91: 104– 115. 26923711 PMC4876822
  20. [21]Weisskopf MG, O’Reilly EJ, McCullough ML, et al. Prospective study of military service and mortality from ALS. Neurology. 2005; 64(1): 32– 37. 15642900
  21. [22]Weisskopf MG, Cudkowicz ME, Johnson N. Military Service and Amyotrophic Lateral Sclerosis in a Population‐based Cohort. Epidemiology. 2015; 26(6): 831– 838. 26414854 PMC4604116
  22. [23]Cragg JJ, Johnson NJ, Weisskopf MG. Military service and amyotrophic lateral sclerosis in a population‐based cohort: extended follow‐up 1979–2011. Epidemiology. 2017; 28(2): e15– e16. 27893489 PMC5285394
  23. [24]Miranda ML, Alicia Overstreet Galeano M, Tassone E, Allen KD, Horner RD. Spatial analysis of the etiology of amyotrophic lateral sclerosis among 1991 Gulf War veterans. Neurotoxicology. 2008; 29(6): 964– 970. 18573277
  24. [25]Yi SW, Ohrr H, Hong JS, Yi JJ. Agent orange exposure and prevalence of self‐reported diseases in Korean Vietnam veterans. J Prev Med Public Heal. 2013; 46(5): 213– 225. PMC3796647 24137524
  25. [27]Fang F, Kwee LC, Allen KD, et al. Association between blood lead and the risk of amyotrophic lateral sclerosis. Am J Epidemiol. 2010; 171(10): 1126– 1133. 20406759 PMC2877471
  26. [28]Peters TL, Beard JD, Umbach DM, et al. Blood levels of trace metals and amyotrophic lateral sclerosis. Neurotoxicology. 2016; 54: 119– 126. 27085208 PMC5451111
  27. [29]Schmidt S, Allen KD, Loiacono VT, et al. Genes and Environmental Exposures in Veterans with Amyotrophic Lateral Sclerosis: the GENEVA study. Rationale, study design and demographic characteristics. Neuroepidemiology. 2008; 30(3): 191– 204. 18421219 PMC2645711
  28. [30]Department of Veterans A. Presumption of service connection for amyotrophic lateral sclerosis. Final rule. Fed Regist 2009; 74(212): 57072– 57074. 20166277
  29. [32]Seals RM, Kioumourtzoglou MA, Hansen J, Gredal O, Weisskopf MG. Amyotrophic lateral sclerosis and the military: a population‐based study in the Danish registries. Epidemiology. 2016; 27(2): 188– 193. 26583610 PMC5119482
  30. [33]Kondo K, Tsubaki T. Case‐Control studies of motor neuron Disease: Association with mechanical injuries. Arch Neurol. 1981; 38(4): 220– 226. 7011280
  31. [34]Malek AM, Barchowsky A, Bowser R, Youk A, Talbott EO. Pesticide exposure as a risk factor for amyotrophic lateral sclerosis: a meta‐analysis of epidemiological studies: pesticide exposure as a risk factor for ALS. Environ Res. 2012; 117: 112– 119. 22819005
  32. [36]Pupillo E, Messina P, Logroscino G, et al. Trauma and amyotrophic lateral sclerosis: A case‐control study from a population‐based registry. Eur J Neurol. 2012; 19(12): 1509– 1517. 22537412
  33. [37]Armon C. Smoking may be considered an established risk factor for sporadic ALS. Neurology. 2009; 73: 1693– 1698. 19917993 PMC2788806
  34. [38]Sagiraju HKR, Zivković S, VanCott AC, et al. Amyotrophic Lateral Sclerosis among Veterans deployed in support of post‐9/11 U.S. conflicts. Mil Med. 2020; 185(3–4): e501– e509. 31642489 PMC8921606
  35. [39]Jellinger KA. The relevance of metals in the pathophysiology of neurodegeneration, pathological considerations. Int Rev Neurobiol. 2013; 110: 1– 47. 24209432

Cited by

Sorted by citations

Authors
McKay, K. A., Smith, K. A., Smertinaite, L., Fang, F., Ingre, C., & Taube, F.
Affiliations
  • Department of Clinical Neuroscience Karolinska Institutet Stockholm Sweden
  • Clinical Epidemiology Division Department of Medicine Solna, Karolinska Institutet Stockholm Sweden
  • Unit of Integrative Epidemiology Insitute of Environmental Medicine Karolinska Institutet Stockholm Sweden
  • School of Public Health and Community Medicine Sahlgrenska Academy at the University of Gothenburg Gothenburg Sweden
ORCID
Venue
Acta Neurologica Scandinavica
Publisher
Wiley
Published
2020-10-12
Volume
143
Issue
1
Pages
39-50
ISSN
  • 0001-6314
  • 1600-0404
DOI
10.1111/ane.13345
PMC
PMC7756624
Cited by
44
References
3
Language
en
Licence
Funders
Försvarsmakten

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review